checkAd
    Startseite > Aktien > Century Therapeutics > Nachrichten
    Century Therapeutics Aktie
    3,0100
     
    USD
    -3,83 %
    -0,1200 USD
    Letzter Kurs 17.05.24 Nasdaq
    3,0000
     
    USD
    200 STK
    Geldkurs 17.05.24
    3,0100
     
    USD
    200 STK
    Briefkurs 17.05.24
    ISIN: US15673T1007 · WKN: A3CSHU · SYM: IPSC · USA

    Neueste Nachrichten

    Century Therapeutics Presents Preclinical Data Highlighting Advances in iPSC Platform Technology and Programs at 2024 ASGCT Annual Meeting
    10.05.24 · globenewswire · Century Therapeutics
    Century Therapeutics Reports First Quarter 2024 Financial Results and Provides Business Updates
    09.05.24 · globenewswire · Century Therapeutics
    Century Therapeutics to Present at Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
    23.04.24 · globenewswire · Century Therapeutics
    Century Therapeutics Strengthens Position in Autoimmune Disease with Strategic Pipeline Expansion Supported by $60 Million Private Placement and Acquisition of Clade Therapeutics
    11.04.24 · globenewswire · Century Therapeutics
    Century Therapeutics Presents New Preclinical Data Highlighting iPSC-derived Cell Therapy Platform Technology at the 2024 American Association for Cancer Research (AACR) Annual Meeting
    08.04.24 · globenewswire · Century Therapeutics
    Century Therapeutics to Present at the H.C. Wainwright 2nd Annual Cell Therapy Virtual Conference
    19.03.24 · globenewswire · Century Therapeutics
    Century Therapeutics Reports Full Year 2023 Financial Results and Provides Business Updates
    14.03.24 · globenewswire · Century Therapeutics
    Century Therapeutics Announces Six Upcoming Poster Presentations at the 2024 American Association for Cancer Research (AACR) Annual Meeting
    06.03.24 · globenewswire · Century Therapeutics
    Century Therapeutics to Present at the Guggenheim Healthcare Talks 6th Annual Biotechnology Conference
    01.02.24 · globenewswire · Century Therapeutics
    Century Therapeutics to Present at the Piper Sandler 35th Annual Healthcare Conference
    21.11.23 · globenewswire · Century Therapeutics
    Century Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Updates
    09.11.23 · globenewswire · Century Therapeutics
    Century Therapeutics Appoints Brent Pfeiffenberger, Pharm.D., MBA, as Chief Executive Officer
    09.11.23 · globenewswire · Century Therapeutics